San Diego-centered Viking Therapeutics marked alone as a serious competitor during the weight loss drug market place in February right after revealing promising facts from the mid-stage demo of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when offered to be a weekly injection and in March the company u